TrialBMJ open ophthalmology2026

Safety and efficacy of biosimilar aflibercept MYL-1701P in diabetic macular oedema: 20-week extension results following the INSIGHT pivotal trial.

Rohan Chauhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.